About ADL Biopharma
ADL Biopharma is a company based in Leon (Spain) founded in 2014 was acquired by Wacker Chemie in May 2023. ADL Biopharma offers products and services including Pilot Plants, Fermentation Plant, and Active Pharmaceutical Ingredients. ADL Biopharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, SeQuent and Sterling Pharma Solutions, among others.
- Headquarter Leon, Spain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Wacker León S.L.U.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Wacker Chemie
& 1 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ADL Biopharma
ADL Biopharma offers a comprehensive portfolio of products and services, including Pilot Plants, Fermentation Plant, and Active Pharmaceutical Ingredients.
Facilities for developing and scaling biotechnologies
Optimizes and scales fermentation protocols for production
Produces sterile APIs under GMP standards
People of ADL Biopharma
Unlock access to complete
Funding Insights of ADL Biopharma
Detailed funding history for ADL Biopharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ADL Biopharma
ADL Biopharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Wacker Chemie and Kartesia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Silicones, polymers, and bio-solutions are manufactured for various industries.
|
Locked | Locked | Locked |
Investor details for ADL Biopharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ADL Biopharma
Investment portfolio details for ADL Biopharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ADL Biopharma
Detailed financials for ADL Biopharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adl Biopharma Comparisons
Peer comparison for ADL Biopharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ADL Biopharma
ADL Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, SeQuent and Sterling Pharma Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
Drug discovery and development service provider
|
Detailed competitors of ADL Biopharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adl Biopharma
Complete news archive for ADL Biopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ADL Biopharma
ADL Biopharma was founded in 2014.
ADL Biopharma is headquartered in Leon, Spain. It is registered at Leon, Castilla Y Leon, Spain.
ADL Biopharma was founded in 2014 and is based in Leon, Spain. Active pharmaceutical ingredients and intermediates are developed and produced by the company within the biopharmaceutical sector. Contract manufacturing services are offered for biofuels, nutraceuticals, enzymes, food supplements, biocatalysts, and vitamins. Operations occur at facilities certified by the US-FDA, supporting various industrial applications.
ADL Biopharma's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
ADL Biopharma offers Pilot Plants, Fermentation Plant, and Active Pharmaceutical Ingredients.
ADL Biopharma has 2 investors. Key investors include Wacker Chemie, and Kartesia.